Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study

Ilana Gory, Michael Anthony Fink, Sally J Bell, Paul Gow, Amanda J Nicoll, Virginia Helen Knight, Anouk Tara Dev, Anthony Rode, Michael John Bailey, Wa Cheung, William Wilson Kemp, Stuart Keith Roberts

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)

Abstract

OBJECTIVES: It remains unclear whether radiofrequency ablation (RFA) provides comparable outcomes to surgical resection (SR). We, therefore, compared survival outcomes of RFA to SR in patients with early stage and very early stage hepatocellular carcinoma (HCC). METHODS: A multicenter retrospective analysis was performed in patients from five academic hospitals with Barcelona Cancer of the Liver Clinic (BCLC) stages 0-A HCC having RFA or SR as primary therapy. RESULTS: From 2000-2010, 146 patients who received treatment with RFA (n = 96) or SR (n = 52) were identified. In BCLC A patients with
Original languageEnglish
Pages (from-to)567 - 576
Number of pages10
JournalScandinavian Journal of Gastroenterology
Volume50
Issue number5
DOIs
Publication statusPublished - 2015

Cite this